Correction (October 18, 2026): Relevant facts and wording have been corrected against primary sources and the original text. Transaction and product status refer to the original reporting period.
In global medical device and MedTech news from July 13-19, 2026, there was significant activity concerning endovascular treatment, ENT, neurostimulation, non-invasive tumor treatment, minimally invasive gynecological surgery, surgical robots, diabetes devices, and M&A.
Regarding new products and approvals, notable developments included Abbott's long Esprit BTK drug-eluting scaffold, Smith+Nephew's COBLATION wand for the larynx, Newronika's adaptive DBS, HistoSonics' Edison histotripsy system, and Claria Medical's tissue retrieval system for hysterectomy.
In M&A, Medtronic completed its acquisition of SPR Therapeutics, and DePuy Synthes acquired spinal implant company Expanding Innovations. For safety-related news, FDA information was updated concerning Medtronic's Harmony pulmonary valve delivery system, ResMed's ventilators, and B. Braun's spinal anesthesia kits.
Key News
1. Abbott Receives FDA Approval for Longer-Length Esprit BTK Drug-Eluting Scaffold
Abbott has received FDA approval for a 76mm longer-length model of its Esprit BTK drug-eluting scaffold, targeting chronic limb-threatening ischemia (CLTI).
The Esprit BTK is a therapeutic device for below-the-knee vascular lesions. It is a scaffold that releases a drug and then is absorbed by the body over a certain period. This new longer-length model may allow for the treatment of longer lesions with fewer devices.
Source: MassDevice - Abbott gets FDA nod for longer length Esprit BTK drug-eluting scaffold
2. Smith+Nephew Launches "LYNX COBLATION Laryngeal Wand" for Laryngeal Surgery
Smith+Nephew has commercially launched the "LYNX COBLATION Laryngeal Wand" for ENT surgery.
This product is a multi-purpose wand that assists with incision, dissection, and tissue reduction in laryngeal surgery. Its features include reduced risk of airway fires due to low-temperature COBLATION technology, a clog-resistant design, and a long working length.
Source: Smith+Nephew - LYNX COBLATION Laryngeal Wand
3. Newronika Obtains CE Mark for Adaptive DBS System
Italian company Newronika has obtained the CE mark for its latest commercial release of the "αDBS" system, an adaptive deep brain stimulation (aDBS) system for Parkinson's disease.
This version includes integration with the company's cloud-based neurodata platform, WebBioBank. In the DBS field, there is an ongoing evolution from fixed stimulation to adaptive systems that adjust stimulation based on the patient's neural activity.
Source: Newronika - CE Mark for αDBS
4. HistoSonics Obtains European CE Mark for Edison Histotripsy System
HistoSonics has received the European CE Mark for its Edison Histotripsy System, which non-invasively destroys liver tumors. This allows for commercialization in Europe and other markets that recognize the CE Mark.
The Edison system utilizes histotripsy technology, which uses focused ultrasound to mechanically destroy tissue. HistoSonics plans a phased European rollout, focusing initially on facilities that treat liver tumors.
Source: HistoSonics - Edison Histotripsy System CE Mark
5. Claria Medical Receives FDA De Novo Authorization for Tissue Containment and Retrieval System for Hysterectomy
Claria Medical has received FDA De Novo authorization for its Claria System, which assists in tissue extraction during minimally invasive hysterectomy.
According to the company, the Claria System is an integrated system for tissue containment and retrieval during hysterectomy. It was also reviewed as a product eligible for the FDA's Safer Technologies Program, STeP.
Sources: Claria Medical - FDA De Novo Authorization FDA - Claria System De Novo
6. Sentante Unveils "Inflante" Digital Indeflator for Endovascular Robotics
Sentante has announced "Inflante," a digital indeflator for balloon dilation procedures.
Inflante replaces manual indeflators with digital control, allowing for the recording of pressure profiles, dilation timing, and procedural data. The company plans to combine Inflante with endovascular robotics to advance the digitalization of cath lab workflows.
Source: MassDevice - Sentante unveils digital indeflator for surgical robot
7. Imperative Care Launches New Guidewire "Ikon 24 Pro" for Stroke Treatment
Imperative Care has launched the "Ikon 24 Pro," a new neurovascular guidewire for acute ischemic stroke treatment.
This product is designed to improve vascular access in stroke procedures. In the neurovascular field, improvements are being made not only to thrombectomy devices but also to peripheral devices such as access catheters and guidewires.
Source: MassDevice - Imperative Care launches new guidewire purpose-built for stroke
8. Abbott to launch Libre Duo internationally in the fall
Abbott has indicated plans to internationally launch "Libre Duo," a dual sensor that simultaneously measures glucose and ketones, this fall.
In the field of diabetes devices, the competitive landscape is expanding from standalone CGMs to comprehensive management systems that include ketone measurement, insulin pumps, and app integration. Abbott also expressed optimism for future reimbursement advancements.
Source: MassDevice - Abbott to launch Libre Duo dual sensor internationally in the fall
9. Surgerii Robotics Installs "SHURUI" Single-Port Surgical Robot in Europe for the First Time
Surgerii Robotics has completed its first European installation of the "SHURUI Single-Port Surgical System" at Vall d'Hebron University Hospital in Barcelona, Spain.
Single-port robots are attracting attention as a technology that supports minimally invasive surgery by reducing the number of incisions. This installation at a major European hospital marks a significant step in the company's international expansion.
Source: MassDevice - Surgerii Robotics first European installation
10. Medtronic Completes Acquisition of SPR Therapeutics
Medtronic has completed its acquisition of SPR Therapeutics, a pain treatment device company. SPR develops minimally invasive peripheral nerve stimulation (PNS) therapy for chronic and acute pain.
Medtronic has an existing neuromodulation business, and this acquisition strengthens its portfolio of non-opioid pain treatments.
Source: Medtronic - Acquisition of SPR Therapeutics Completed
11. DePuy Synthes Acquires Spinal Implant Company Expanding Innovations
DePuy Synthes, part of Johnson & Johnson MedTech, has acquired Expanding Innovations, a company with expandable implant technology for spinal surgery.
Expanding Innovations develops X-PAC expandable implant technology, which DePuy Synthes plans to integrate into its TriALTIS Spine System and VELYS Enabling Tech portfolio for Spine.
Source: Johnson & Johnson - DePuy Synthes Acquires Expanding Innovations
12. FDA Updates Recall Information for Medtronic Harmony Delivery System and Others
The FDA has posted recall information regarding Medtronic's Harmony Pulmonary Valve Delivery System. The recall applies to certain catheter delivery systems that deliver the pulmonary valve, but the valve itself is not included.
Additionally, the FDA updated information that same week concerning ResMed's ventilators (Early Alert), B. Braun's spinal anesthesia kits, Arrow International's convenience kits, and Abiomed's 14Fr Low Profile Introducer Kit, among others.
Source: FDA - CDRH New: News and Updates FDA - Medical Device Recalls and Early Alerts
Summary
In medical device and MedTech news from July 13-19, 2026, new product and approval-related movements were prominent, including Abbott's long Esprit BTK, Smith+Nephew's LYNX COBLATION, Newronika's adaptive DBS, HistoSonics' Edison histotripsy system, and Claria Medical's tissue retrieval system for hysterectomy.
Furthermore, product development progressed in the areas of procedural support, robotics, digitalization, and diabetes management, with Sentante's digital balloon inflation device (indeflator), Imperative Care's guidewire for stroke, Abbott's Libre Duo, and Surgerii Robotics' first European installation of a single-port surgical robot.
In M&A, Medtronic completed its acquisition of SPR Therapeutics, and DePuy Synthes acquired Expanding Innovations. Regarding safety, FDA information was updated for Medtronic's Harmony Pulmonary Valve Delivery System, ResMed ventilators, B. Braun and Arrow kit products, and Abiomed introducer kits.
This week saw new products, approvals, and business restructuring across a wide range of fields, from endovascular therapy, neurostimulation, non-invasive tumor treatment, gynecological surgery, ENT, diabetes, and medical robotics, to orthopedic implants.